|
|

|
|
Amy Anderson Ph.D. Associate Professor of Medicinal Chemistry
University of Connecticut School of Pharmacy 69 North Eagleville Road, Unit 3092 Storrs, Connecticut 06269-3092
Phone: (860) 486-6145 Fax: (860) 486-6857 E-Mail:amy.anderson@uconn.edu Lab/Research Website
|
Educational Background
| ◊ |
B.S. Massachusetts Institute of Technology, Life Sciences
|
| |
|
| ◊ |
Ph.D. Harvard University, Biophysics
|
| |
|
| ◊ |
Postdoctoral Training: University of California, San Francisco, Biophysics and Biochemistry
|
Research Interests
| ◊ |
Structure-based drug design, using X-ray crystallography and molecular modeling, to discover small molecule inhibitors for protein targets of infectious diseases.
|
| |
|
Selected Publications
| ◊ |
Beierlein, J., Deshmukh, L., Frey, K., Vinogradova, O. and Anderson, A. (2009) “The Solution Structure of Bacillus anthracis Dihydrofolate Reductase Yields Insight into the Analysis of Structure-Activity Relationships for Novel Inhibitors” Biochemistry 48: 4100-4108. |
| |
|
| ◊ |
Frey, K., Liu, J., Lombardo, M., Bolstad, D., Wright, D. and Anderson, A. (2009) “Crystal Structures of Wild-type and Mutant Methicillin-resistant Staphylococcus aureus Dihydrofolate Reductase Reveal an Alternative Conformation of NADPH that may be Linked to Trimethoprim Resistance” J. Mol. Biol. 387: 1298-1308. |
| |
|
| ◊ |
Chen, C-Y., Georgiev, I., Anderson, A. and Donald, B. (2009) “Computational Structure-Based Redesign of Enzyme Activity” Proc. Natl. Acad. Sci. 106: 3764-3769. |
| |
|
| ◊ |
Sundstrom, T., Anderson, A. and Wright, D. (2009) “Inhibitors of phosphoinositide-3-kinase: a structure-based approach to understanding potency and selectivity” Org. Biomol. Chem. 7: 840-850. |
| |
|
| ◊ |
Liu, J., Bolstad, D., Smith, A., Priestley, N., Wright, D. and Anderson, A. (2009) “Probing the active site of Candida glabrata dihydrofolate reductase with high resolution crystal structures and the synthesis of new inhibitors” Chem. Biol. Drug Des. 73:62-74. |
| |
|
| ◊ |
Liu, J., Bolstad, D., Bolstad, E., Wright, D. and Anderson, A. (2009) “Towards New Antifolates Targeting Eukaryotic Opportunistic Infections” Euk. Cell, 8: 483-486. |
| |
|
| ◊ |
Bolstad, E. and Anderson, A. (2009) “In pursuit of virtual lead optimization: Pruning ensembles of receptor structures for increased efficiency and accuracy during docking” Proteins, 75: 62-74. |
| |
|
| ◊ |
Blauvelt, M., Khalili, M., Jang, W., Paulsen, J., Anderson, A., Wilson, S. B. and Howell, A. (2008) “α-S-GalCer: Synthesis and Evaluation for iNKT Cell Stimulation” Bioorg. Med. Chem. Lett.,18: 6374-6376. |
| |
|
| ◊ |
Beierlein, J., Frey, K., Bolstad, D., Pelphrey, P., Joska, T., Smith, A., Priestley, N., Wright, D. and Anderson, A. (2008) “Synthetic and Crystallographic Studies of a New Inhibitor Series Targeting Bacillus anthracis Dihydrofolate Reductase” J. Med. Chem., 51: 7532-7540. |
| |
|
| ◊ |
Bolstad, D., Bolstad, E., Frey, K., Wright, D. and Anderson, A. (2008) “A structure-based approach to the development of potent and selective inhibitors of dihydrofolate reductase from Cryptosporidium” J. Med. Chem., 51:6839-6852. |
| |
|
| ◊ |
Liu, J., Bolstad, D., Smith, A., Priestley, N., Wright, D. and Anderson, A. (2008) “Structure-guided development of efficacious antifungal agents targeting Candida glabrata dihydrofolate reductase” Chem. Biol. 15: 990-996. |
|